Audience · trials, evidence and partnering

For Industry

A molecular intelligence platform, an exclusive clinical partner, and a growing consented patient network.

01Trials, evidence and partnering

From biomarker hypothesis to real-world answer

We pair a molecular intelligence platform with an exclusive clinical partner and a growing, consented patient network. For life-sciences partners that shortens the distance to an answer, in recruitment, evidence generation and diagnostic strategy.

Biomarker-matched trial recruitment

Our TrialGraph layer matches comprehensively profiled patients to eligibility criteria at the molecular level, and our clinical partner can support site-level conduct.

Molecular pre-screening

Against protocol eligibility, before a site visit.

A consented population

Comprehensively profiled, including rare-biomarker cohorts.

Site-level support

Clinical-partner support for enrolment and conduct.

Diagram placeholder

Molecular pre-screening funnel

What goes here: Funnel diagram: a broad profiled population narrowing through eligibility criteria to a small matched cohort, with the conventional screening path shown alongside for contrast. Annotate where time and screening failures are saved. Keep the numbers illustrative and clearly labelled as such.

What we offer partners

Real-world evidence

Linked clinicogenomic datasets

We follow patients longitudinally: baseline profiling, serial monitoring, outcomes. With consent and governance, that supports outcomes research, drug-performance studies and post-market surveillance in the Indian population, where such data is scarce.

Companion diagnostics

Biomarker strategy

We support biomarker discovery and companion-diagnostic strategy, from exploratory analyses on consented cohorts through to structured validation.

Interpretation as a service

Decision-grade reporting on your data

Through the Decipher pathway we can provide interpretation and tumour board sign-out on data generated elsewhere, so laboratories and hospitals can add decision-grade reporting without building their own stack.

Screening programmes

Bespoke genetic screening

For corporate, insurer and population-health partners we design and run targeted screening programmes, with counselling and governance built in. We help define what to screen for, why, and how results are responsibly returned.

Partner with us

Tell us the question you are trying to answer: a recruitment target, an evidence gap, a diagnostic strategy. We will tell you honestly whether we can help.

Start a partnership conversation

Take the next step

Three ways forward. Pick the one that fits today.

Book a free consultation

A no-obligation conversation with our care team, arranged through KPCIRC.

Book a consultation

Begin Blueprint Care

Commission your decision report and a dedicated clinical team.

Explore Blueprint Care

Ask on WhatsApp, free

Signal replies to your first question within four hours, at no cost.

Start with Signal